Intra-Cellular Therapies
ITCI
#1265
Rank
S$18.45 B
Marketcap
$173.28
Share price
0.00%
Change (1 day)
72.11%
Change (1 year)

Earnings for Intra-Cellular Therapies (ITCI)

Earnings in 2024 (TTM): -S$98.63 Million

According to Intra-Cellular Therapies's latest financial reports the company's current earnings are S$0.68 Billion. , an increase over its 2023 earnings that were of -S$0.19 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Intra-Cellular Therapies from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -S$97.51 Million-46.63%
2023 -S$0.19 Billion-45.74%
2022 -S$0.34 Billion-9.81%
2021 -S$0.38 Billion25.17%
2020 -S$0.3 Billion53.66%
2019 -S$0.2 Billion-4.77%
2018 -S$0.21 Billion56.96%
2017 -S$0.13 Billion-14.33%
2016 -S$0.16 Billion10.09%
2015 -S$0.14 Billion241.45%
2014 -S$40.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$14.52 Million-85.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$56.21 Million-42.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.32 Billion 227.43%๐Ÿ‡บ๐Ÿ‡ธ USA